Multiplex Sensing of Biomarkers on the Cancer Cell Surface by an Epithelial-Mesenchymal Transition (EMT) Sensing Panel Enables Precise Differentiating of Cancer Cells at Various EMT Stages
Analytical Chemistry · 13.08.2024 · 96 (32) · 13270-13277
DOI: 10.1021/acs.analchem.4c02474 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, online erschienen am 02.08.2024. Verfasst von Siyi Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for Analytical Sciences, Department of Chemistry, College of Sciences, Northeastern University, Shenyang 110819, China. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Biomarkers, Tumor, Cadherins. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Liaoning Revitalization Talents Program, Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China.
Abstract (Originalsprache)
Epithelial-mesenchymal transition (EMT) is a complex process that plays a critical role in tumor progression. In this study, we present an EMT sensing panel for the classification of cancer cells at different EMT stages. This sensing panel consists of three types of fluorescent probes based on boronic acid-functionalized carbon-nitride nanosheet (BCN) derivatives. The selective response toward different EMT-associated biomarkers, namely, EpCAM, N-cadherin, and sialic acid (SA), was achieved by conjugating the corresponding antibodies to each BCN derivative, whereas the rare-earth-doping ensures simultaneous sensing of the three biomarkers with fluorescent emission of the three probes at different wavelengths. Sensitive sensing of the three biomarkers was achieved at the protein level with LODs reaching 1.35 ng mL-1 for EpCAM, 1.62 ng mL-1 for N-cadherin, and 1.54 ng mL-1 for SA. The selective response of these biomarkers on the cell surface also facilitated sensitive detection of MCF-7 cells and MDA-MB-231 cells with LODs of 2 cells/mL and 2 cells/mL, respectively. Based on the simultaneous sensing of the three biomarkers on cancer cells that underwent different extents of EMT, precise discrimination and classification of cells at various EMT stages were also achieved with an accuracy of 93.3%. This EMT sensing panel provided a versatile tool for monitoring the EMT evolution process and has the potential to be used for the evaluation of the EMT-targeting therapy and metastasis prediction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Research Center for Analytical Sciences, Department of Chemistry, College of Sciences, Northeastern University, Shenyang 110819, China.
- Institute of Medical Technology, Shanxi Medical University, Taiyuan 030001, China.
ORCID-Profile: Ting Yang, Jian-Hua Wang
Förderung
- Liaoning Revitalization Talents Program
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
Zitieren
APA
Wang, S., Guo, Y., Wang, X., Zhang, X., Yang, T., & Wang, J. H. (2024). Multiplex Sensing of Biomarkers on the Cancer Cell Surface by an Epithelial-Mesenchymal Transition (EMT) Sensing Panel Enables Precise Differentiating of Cancer Cells at Various EMT Stages. Analytical Chemistry, 96(32), 13270-13277. https://doi.org/10.1021/acs.analchem.4c02474
Vancouver
Wang S, Guo Y, Wang X, Zhang X, Yang T, Wang JH. Multiplex Sensing of Biomarkers on the Cancer Cell Surface by an Epithelial-Mesenchymal Transition (EMT) Sensing Panel Enables Precise Differentiating of Cancer Cells at Various EMT Stages. Analytical Chemistry. 2024;96(32):13270-13277. doi:10.1021/acs.analchem.4c02474
BibTeX
@article{Wang2024,
author = {Wang, Siyi and Guo, Yushuang and Wang, Xin and Zhang, Xuan and Yang, Ting and Wang, Jian-Hua},
title = {Multiplex Sensing of Biomarkers on the Cancer Cell Surface by an Epithelial-Mesenchymal Transition (EMT) Sensing Panel Enables Precise Differentiating of Cancer Cells at Various EMT Stages},
journal = {Analytical Chemistry},
year = {2024},
volume = {96},
number = {32},
pages = {13270--13277},
doi = {10.1021/acs.analchem.4c02474}
}
EUVIMED